IL10 and Miyoshi myopathy: In our study, the significant correlation between IL-10 levels and ISS stage (p = 0.028) highlights the importance of this immunomodulatory cytokine in the pathophysiology of MM and suggests that it may serve as a marker of disease burden or activity.